Advanced search
Publication Cover
The Physician and Sportsmedicine Volume 47, 2019 - Issue 1
Submit an article Journal homepage
2,079
Views
23
CrossRef citations to date
0
Altmetric
Clinical Features - Review

Anabolic-androgenic steroids: procurement and administration practices of doping athletes

Julius FinkGraduate School of Medicine, Department of Metabolism and Endocrinology, Juntendo University, Tokyo, JAPANCorrespondence[email protected]
View further author information
,
Brad Jon SchoenfeldDepartment of Health Sciences, Lehman College, Bronx, NY, USAView further author information
,
Anthony C. HackneyDepartment of Exercise & Sport Science; Department of Nutrition – School of Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, USAView further author information
,
Masahito MatsumotoAdvanced Diabetic Therapeutics, Department of Metabolic Endocrinology, Juntendo University, Tokyo, JapanView further author information
,
Takahiro MaekawaDepartment of Rehabilitation for the Movement Functions Research Institute, National Rehabilitation Center for Persons with Disabilities, Saitama, JapanView further author information
,
Koichi NakazatoGraduate Schools of Health and Sport Science, Nippon Sport Science University, Tokyo, JAPANView further author information
&
Shigeo HorieGraduate School of Medicine, Department of Urology, Juntendo University, TokyoJapanView further author information
 show all
Pages 10-14 | Received 01 Jun 2018, Accepted 18 Sep 2018, Published online: 01 Oct 2018

References

  • Alen M, Häkkinen K, Komi P. Changes in neuromuscular performance and muscle fiber characteristics of elite power athletes self‐administering androgenic and anabolic steroids. Acta Physiol Scand. 1984;122:535–544.
  • Pope HG, Kanayama G, Ionescu‐Pioggia M, et al. Anabolic steroid users’ attitudes towards physicians. Addiction. 2004;99:1189–1194.
  • Cohen J, Collins R, Darkes J, et al. A league of their own: demographics, motivations and patterns of use of 1,955 male adult non-medical anabolic steroid users in the United States. J Int Soc Sports Nutr. 2007;4:12.
  • Cordaro FG, Lombardo S, Cosentino M. Selling androgenic anabolic steroids by the pound: identification and analysis of popular websites on the Internet. Scand J Med Sci Sports. 2011;21:e247–e259.
  • Perry PJ, Lund BC, Deninger MJ, et al. Anabolic steroid use in weightlifters and bodybuilders: an internet survey of drug utilization. Clin J Sport Med. 2005;15:326–330.
  • Bhasin S, Cunningham GR, Hayes FJ, et al. Testosterone therapy in men with androgen deficiency syndromes: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2010;95:2536–2559.
  • Weissberger AJ, Ho K. Activation of the somatotropic axis by testosterone in adult males: evidence for the role of aromatization. J Clin Endocrinol Metab. 1993;76:1407–1412.
  • Parkinson AB, Evans NA. Anabolic androgenic steroids: a survey of 500 users. Med Sci Sports Exercise. 2006;38:644–651.
  • Weber C, Krug O, Kamber M, et al. Qualitative and semiquantitative analysis of doping products seized at the Swiss Border. Subst Use Misuse. 2017;52:742–753.
  • da Justa Neves DB, Marcheti RGA, Caldas ED. Incidence of anabolic steroid counterfeiting in Brazil. Forensic Sci Int. 2013;228:e81–e83.
  • Teck JTW, McCann M. Tracking internet interest in anabolic-androgenic steroids using Google Trends. Int J Drug Policy. 2018;51:52–55.
  • Saugy M, Robinson N, Saudan C, et al. Human growth hormone doping in sport. Br J Sports Med. 2006;40:i35–i39.
  • Basaria S, Collins L, Dillon EL, et al. The safety, pharmacokinetics, and effects of LGD-4033, a novel nonsteroidal oral, selective androgen receptor modulator, in healthy young men. J Gerontol Ser A: Biomed Sci Med Sci. 2010;68:87–95.
  • Choi SM, Lee B-M. Comparative safety evaluation of selective androgen receptor modulators and anabolic androgenic steroids. Expert Opin Drug Saf. 2015;14:1773–1785.
  • Dalton JT, Taylor RP, Mohler ML, et al. Selective androgen receptor modulators for the prevention and treatment of muscle wasting associated with cancer. Curr Opin Support Palliat Care. 2013;7:345–351.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.